Science News & Science Current Events
 
Email a Friend Send to a friend
Printer Friendly Print Scientists Determine Drug Target for the Most Potent Botulinum Neurotoxin

Scientists Determine Drug Target for the Most Potent Botulinum Neurotoxin

April 30, 2008

Botulinum neurotoxin -- responsible for the deadly food poisoning disease botulism and for the beneficial effects of smoothing out facial wrinkles - can also be used as a dreaded biological weapon. When ingested or inhaled, less than a billionth of an ounce can cause muscle paralysis and eventual death. Although experimental vaccines administered prior to exposure can inhibit the destructive action of this neurotoxin - the most deadly protein known to humans -- no effective pharmacological treatment exists.

Now, scientists at the U.S. Department of Energy's Brookhaven National Laboratory and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) have taken the first step toward designing an effective antidote to the most potent form of the toxin. They have found that they can trick the toxin to bypass its normal binding protein, thereby blocking its deadly action. The results of their research are reported in the April 22, 2008 online issue of the Journal of Biological Chemistry.




"We have found a highly efficient inhibitor of botulinum neurotoxin type A - the most potent of seven neurotoxins produced by the bacterium Clostridium botulinum. This finding can lead to a very effective drug to stop the devastating effects of the toxin," said Brookhaven Lab biologist Subramanyam Swaminathan, the study's co-principal investigator. "We intend to do further research to tailor the inhibitor for the best results."

"We are excited about the success of this work and the prospects it holds for future drug development," said USAMRIID principal investigator S. Ashraf Ahmed, who initiated the structure-based inhibitor design as part of the Institute's bio-defense research program.

To cause its deadly effects, the botulinum neurotoxin first binds to a nerve cell membrane, which curves inward, incorporating the toxin into a vesicle that drifts inside the cell. The toxin eventually travels from the vesicle to the cytosol, the internal fluid of the cell. The toxin then cleaves specific proteins in the cytosol, thereby blocking the release of neurotransmitters - chemicals nerve cells use to communicate with one another and with muscles. Blockage of this communication paralyzes muscles - including those that enable breathing.

To block the toxin's action, the researchers designed four "decoy" protein fragments that mimic the structure of the protein to which the toxin ordinarily binds. The toxin then attaches itself to the decoy fragments instead of to the cell's protein. This re-routing of the toxin allows neurotransmitters to keep functioning, thus stopping the toxin's pathological effects.

The scientists used x-ray techniques at Brookhaven's National Synchrotron Light Source (NSLS) to see how the toxin binds to the protein inhibitors. They found that all four decoy proteins are efficient at inhibiting the toxin's binding to the cell's protein, but one of them in particular is by far the best of any known inhibitors. The scientists' next step in this process is to transform the most effective of the four protein fragments into a drug-like molecule before clinical testing is done.

"This study represents an impressive collaboration in identifying potential inhibitors of the toxin for therapeutic use," said Colonel George W. Korch, Jr., USAMRIID's commander. "It builds upon the successes we have realized in developing effective next-generation vaccines to protect our citizens against the toxin's deadly effects prior to exposure."

The scientists did not work with intact Clostridium botulinum bacteria. Instead, they produced a functional fragment of the neurotoxin protein, which is not toxic. The research is performed in strict compliance with Brookhaven's Institutional Biosafety Committee regulations according to standards set by the U.S. Centers for Disease Control and Prevention. Only authorized scientists have access to the laboratory.

This research was funded by the Defense Threat Reduction Agency of the U.S. Department of Defense. The NSLS is supported by the U.S. Department of Energy's Office of Basic Energy Sciences, Office of Science.

Brookhaven National Laboratory



Related Botulinum Neurotoxin Current Events and Botulinum Neurotoxin News Articles Botulinum Neurotoxin Current Events and Botulinum Neurotoxin News RSS Botulinum Neurotoxin Current Events and Botulinum Neurotoxin News RSS
Researchers develop new ultrasensitive assay to detect most poisonous substance known
Scientists at City of Hope and the California Department of Public Health have developed a new ultrasensitive assay to detect botulinum neurotoxin.

Scripps research scientists: Compounds show significant promise against potential bioweapon toxins
Because of the high cost and limited applicability of currently available treatments, the newly identified compounds have the potential to fill the existing therapy gap and to provide protection against a bioterrorism attack using the toxin.

Study helps explain why botulinum toxin is so deadly
A pilot without a map can locate an airport by first finding a nearby landmark, like a big river, and then searching for the airport.

Botulism study could lead to new vaccines and treatments to counter bioterrorist attacks
Of all the weapons in the bioterrorist arsenal, none is as potent as botulinum neurotoxin, which causes botulism-a potentially fatal disease with symptoms that include severe paralysis of the limbs and respiratory muscles.

Molecular structure reveals how botulinum toxin attaches to nerve cells
Botulism is a life-threatening disease caused by exposure to botulinum neurotoxins, which are among the most potent toxins known. These neurotoxins are produced by Clostridium botulinum, a bacterium found in soil and food.

Seeing a neurotoxin's deadly grip
Two Howard Hughes Medical Institute research teams working independently have discovered new information about how the botulinum neurotoxin shuts down neurons with deadly efficiency.

New wrinkle in Botox treatment could lead to lower doses, better safety
There may soon be a better way to fight unsightly wrinkles. Researchers have discovered a novel way to increase the potency of botulinum neurotoxin treatments - commonly known as Botox - that they say could one day allow patients to receive the injections less frequently while maintaining or even enhancing its cosmetic benefits.

Scientists reveal how deadly toxin hijacks cells
Scientists have pinpointed exactly how botulinum neurotoxin A-a potential agent of biological warfare and one of the most lethal toxins known to man-is able to sneak into cells.

Newly discovered small molecules
According to the study, these activators bind to specific sites on the neurotoxin protein, increasing protease activity and enhancing the toxin's effect.

Botox could help target resistant tumors for treatment
The cosmetic treatment Botox may have a new use as an adjuvant to cancer therapy, providing an open door for chemotherapy and radiation treatments.
More Botulinum Neurotoxin Current Events and Botulinum Neurotoxin News Articles
Botulinum neurotoxin detection and differentiation by mass spectrometry.: An article from: Emerging Infectious Diseases
by John R. Barr, Hercules Moura, Anne E. Boyer, Adrian R. Woolfitt, Suzanne R. Kalb, Antonis Pavlopoulos, Lisa G. McWilliams, Jurgen G. Schmidt, Rodolfo A. Martinez, David L. Ashley

This digital document is an article from Emerging Infectious Diseases, published by Thomson Gale on October 1, 2005. The length of the article is 4407 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...



Enzyme-amplified protein microarray and a fluidic renewable surface fluorescence immunoassay for botulinum neurotoxin detection using high-affinity recombinant ... [An article from: Analytica Chimica Acta]
by S.M. Varnum, M.G. Warner, B. Dockendorff, Anheier

This digital document is a journal article from Analytica Chimica Acta, published by Elsevier in 2006. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.Description: Two immunoassay platforms were developed for either the sensitive or rapid detection of botulinum neurotoxin A (BoNT/A), using...



Plastic enzyme-linked immunosorbent assays (ELISA)-on-a-chip biosensor for botulinum neurotoxin A [An article from: Analytica Chimica Acta]
by S.M. Han, J.H. Cho, I.H. Cho, E.H. Paek, H.B. Oh

This digital document is a journal article from Analytica Chimica Acta, published by Elsevier in 2007. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.Description: A plastic ELISA-on-a-chip (EOC) employing the concept of cross-flow immuno-chromatographic analysis was applied to the...

Botulinum Neurotoxin and Tetanus Toxin



Botulinum and Tetanus Neurotoxins

Botulinum and Tetanus Neurotoxins
by Editor-B.R. DasGupta



Treatments from Toxins: The Therapeutic Potential of Clostridial Neurotoxins

As little as two decades ago, deliberately injecting botulinum toxin into patients would have seemed foolhardy at best and criminal at worst. The increased clinical use of botulinum toxins has expanded the body of knowledge available on the structure and function of these proteins. This knowledge can be applied to topics as varied as therapies based on the endopeptidase activity of the toxins,...

Neurotoxin and epitope structural studies
by Donald F Hunt

© 2008 BrightSurf.com